Why Otonomy Shares Dipped By Around 54%; Here Are 67 Biggest Movers From Yesterday
Gainers
Nutex Health Inc. (NASDAQ: NUTX) jumped 72.4% to settle at $0.9551 on Thursday. Nutex Health recently provided a corporate update.
Dow Surges 950 Points; S&P 500 Rises 3%
U.S. stocks traded higher toward the end of trading, with the Dow Jones jumping around 950 points on Thursday.
Oppenheimer Downgrades Relmada Therapeutics to Perform
Oppenheimer analyst Jay Olson downgrades Relmada Therapeutics (NASDAQ:RLMD) from Outperform to Perform.
Why Laser Photonics Shares Are Trading Higher By Around 44%, Here Are 50 Stocks Moving In Thursday’s Mid-Day Session
Gainers
FedNat Holding Company (NASDAQ: FNHC) shares jumped 89% to $0.4242 after dipping 34% on Wednesday.
Gold Down 1.5%; Domino’s Pizza Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 150 points on Thursday.
Progressive, Asana And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded lower, with the Dow Jones gaining more than 100 points on Thursday. Here are some big stocks recording losses in today’s session.
Goldman Sachs Maintains Buy on Relmada Therapeutics, Raises Price Target to $81
Goldman Sachs analyst Andrea Tan maintains Relmada Therapeutics (NASDAQ:RLMD) with a Buy and raises the price target from $49 to $81.
Relmada Therapeutics Announces Completion Of Treatment In Company’s Registrational Phase 3 RELIANCE III Trial For Rel-1017 As A Monotherapy For Major Depressive Disorder
Relmada Therapeutics, Inc. (NASDAQ:RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced the completion of patient treatment in RELIANCE III, a monotherapy
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell
• Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.